SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001674796-24-000003
Filing Date
2024-04-05
Accepted
2024-04-05 16:16:56
Documents
51
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 HST GLOBAL, INC. - FORM 10-K SEC FILING hstc-20231231.htm   iXBRL 10-K 259191
2 exhibit31-1.htm EX-31 7984
3 exhibit31-2.htm EX-31 7974
4 exhibit32-1.htm EX-32 3657
5 exhibit32-2.htm EX-32 3774
  Complete submission text file 0001674796-24-000003.txt   1520753

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hstc-20231231_cal.xml EX-101.CAL 14334
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20231231_def.xml EX-101.DEF 22276
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20231231_lab.xml EX-101.LAB 94341
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20231231_pre.xml EX-101.PRE 80624
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20231231.xsd EX-101.SCH 19884
55 EXTRACTED XBRL INSTANCE DOCUMENT hstc-20231231_htm.xml XML 97024
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

IRS No.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15303 | Film No.: 24826737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)